Drug Topics

The first participant in a phase 1/2 clinical #trial of Z-1018, an investigational #vaccine candidate being developed by Dynavax Technologies for the prevention of #herpes zoster (#shingles), the company announced. https://lnkd.in/e9GkTv_5

The #OTC medicine space represents a prime #opportunity for independent #pharmacies to increase foot traffic and boost #profits, according to Peter Koo, PharmD, RPh, vice president and general manager of Pharmacy & Healthcare Solutions at McKesson. Drug Topics spoke with Koo during an #interview at #McKessonideaShare2024, held June 23 to 26 in New Orleans, Louisiana. https://lnkd.in/eP392QKk

While independent #pharmacists are currently facing #revenue issues within a dynamic #pharmacy market, Emily Flaugher, vice president and general manager of Health Mart Atlas and Atlas Specialty at McKesson, said that if #community pharmacists can use a combination of McKesson’s resources at their disposal, they will be able to reclaim a maximized amount of #reimbursement dollars and fully execute on opportunities for #profitability. https://lnkd.in/enV6ESQQ

As part of its ongoing inquiry into the #business operations of the top #pharmacy benefit managers (#PBMs), the Federal Trade Commission released an interim #report that detailed PBMs’ immense power in determining #prescription drug access and #affordability to the detriment of independent pharmacies and their #patients. The report highlighted the #extreme market control of CVS Health Corporation, The Cigna Group, UnitedHealth Group, Humana Inc, MedImpact Healthcare Systems, Inc., and Blue Cross Blue Shield Association. https://lnkd.in/e_J8hWyD

#Tirzepatide is associated with significantly more #weight loss than #semaglutide in adults with #overweight or #obesity, according to results of a real-world study published in JAMA Internal Medicine. https://lnkd.in/eSMwKkgK

Combining sodium glucose co-transporter 2 inhibitors (#SGLT2is) with glucagon-like peptide-1 receptor agonists (GLP-1RAs) may offer additional protection against #cardiovascular and #kidney disease in patients with type 2 #diabetes, according to the results of a new meta-analysis published in The Lancet Diabetes & Endocrinology and presented at the 61st European Renal Association Congress in Stockholm, Sweden. https://lnkd.in/eSXUWJfg

Despite #gastrointestinal issues being common adverse effects for patients using #semaglutide, a new possible event has garnered traction among patients with type 2 #diabetes or #obesity looking to treat their conditions. #Researchers have recently assessed the association between semaglutide use and the risk of nonarteritic anterior ischemic optic #neuropathy, “the second most common form of optic neuropathy and a significant cause of blindness among adults." https://lnkd.in/eAtnD4_z

Gain insights on overcoming industry challenges & optimizing your pharmacy's success. Plus, enter to win a $50 Amazon gift card! Register now for the webinar: “The 2024 Smarter Purchasing Report: Uncover 5 Key Pharmacy Trends,” sponsored by SureCost on July 24th. https://lnkd.in/e4QennRS

Register for the Total Pharmacy Solutions® Summit and unlock new income streams with @NimbleRx. Don't miss this chance to streamline your pharmacy operations! https://ow.ly/3Tuz50SmNqz

Vaccination with Abrysvo, Pfizer’s nonadjuvanted bivalent respiratory syncytial virus (#RSV) prefusion F (RSVpreF) protein subunit #vaccine, was not associated with an increased risk of preterm #birth among pregnant individuals who received the vaccine, according to research results published in JAMA Network Open. https://lnkd.in/eU6dWps4